BPC-157

BPC-157 is a synthetic peptide studied for tissue repair, but human evidence is limited and its safety remains uncertain.

• 1. Potential healing mechanism: Animal studies suggest it can promote fibroblast migration and new blood-vessel growth, increasing blood flow and delivery of growth factors to injured tissue. Systemic or subcutaneous injections are reported to help injuries distant from the injection site, although how it reaches those sites is unclear. 1 2 3
• 2. Evidence for recovery: Animal research and anecdotal reports describe faster recovery, but rigorous human research is sparse; one human study is described as a weak self-report rather than a clinical trial. 4 5
• 3. Tumor-growth concern: Because BPC-157 may increase blood-vessel growth and growth-factor delivery, there is a theoretical concern it could support tumor growth, especially for people with known or suspected cancer. The transcript also notes that animal studies have not shown a cancer signal, while emphasizing that human risk is not established. 6 7
• 4. Dose and caution: A commonly described regimen is 300–500 micrograms subcutaneously two or three times weekly, but this is not a recommendation to use it. The discussion advises using the minimum effective dose, avoiding continuous use, monitoring health, and consulting a physician. 8 9